Insider trading

Period: 120 months Stock: TARS + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

227 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

227 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

227 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

227 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
227 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
227 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

227 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
21 Apr 2023
Azamian Bobak R. President/CEO and Board Chair · indirect
Sold on a plan
$34.73K 2,311 at 15.03
0.2%
Planned (10b5-1)
20 Apr 2023
Greenstein Leonard M. Chief Financial Officer
Sold on a plan
$70.10K 5,000 at 14.02
15.7%
Planned (10b5-1)
19 Apr 2023
Azamian Bobak R. President/CEO and Board Chair · indirect
Sold on a plan
$108.80K 8,000 at 13.60
0.7%
Planned (10b5-1)
23 Mar 2023
Azamian Bobak R. President/CEO and Board Chair
Sold at will
$8.95K 737 at 12.15
7.9%
Not planned
23 Mar 2023
Trevejo Jose M. CHIEF MEDICAL OFFICER
Sold at will
$5.65K 465 at 12.15
7.1%
Not planned
23 Mar 2023
Neervannan Seshadri Chief Operating Officer
Sold at will
$4.74K 390 at 12.15
0.7%
Not planned
23 Mar 2023
Mottiwala Aziz Chief Commercial Officer
Sold at will
$4.52K 372 at 12.15
0.7%
Not planned
23 Mar 2023
Wahl Bryan General Counsel
Sold at will
$4.51K 371 at 12.15
2.2%
Not planned
23 Mar 2023
Greenstein Leonard M. Chief Financial Officer
Sold at will
$4.20K 346 at 12.15
1.1%
Not planned
23 Mar 2023
Whitfield Dianne C. Chief Human Resources Officer
Sold at will
$4.19K 345 at 12.15
3.0%
Not planned
22 Mar 2023
Azamian Bobak R. President/CEO and Board Chair
Sold at will
$8.96K 709 at 12.64
7.1%
Not planned
22 Mar 2023
Trevejo Jose M. CHIEF MEDICAL OFFICER
Sold at will
$6.69K 529 at 12.64
7.4%
Not planned
22 Mar 2023
Neervannan Seshadri Chief Operating Officer
Sold at will
$4.79K 379 at 12.64
0.7%
Not planned
22 Mar 2023
Wahl Bryan General Counsel
Sold at will
$4.51K 357 at 12.64
2.1%
Not planned
22 Mar 2023
Mottiwala Aziz Chief Commercial Officer
Sold at will
$4.51K 357 at 12.64
0.7%
Not planned
22 Mar 2023
Whitfield Dianne C. Chief Human Resources Officer
Sold at will
$4.21K 333 at 12.64
2.8%
Not planned
22 Mar 2023
Greenstein Leonard M. Chief Financial Officer
Sold at will
$4.20K 332 at 12.64
1.0%
Not planned
21 Mar 2023
Azamian Bobak R. President/CEO and Board Chair
Sold at will
$8.75K 679 at 12.89
6.3%
Not planned
21 Mar 2023
Trevejo Jose M. CHIEF MEDICAL OFFICER
Sold at will
$6.69K 519 at 12.89
6.8%
Not planned
21 Mar 2023
Neervannan Seshadri Chief Operating Officer
Sold at will
$4.80K 372 at 12.89
0.7%
Not planned
21 Mar 2023
Wahl Bryan General Counsel
Sold at will
$4.51K 350 at 12.89
2.0%
Not planned
21 Mar 2023
Mottiwala Aziz Chief Commercial Officer
Sold at will
$4.50K 349 at 12.89
0.6%
Not planned
21 Mar 2023
Greenstein Leonard M. Chief Financial Officer
Sold at will
$4.20K 326 at 12.89
1.0%
Not planned
21 Mar 2023
Whitfield Dianne C. Chief Human Resources Officer
Sold at will
$4.20K 326 at 12.89
2.7%
Not planned
20 Mar 2023
Azamian Bobak R. President/CEO and Board Chair
Sold at will
$9.34K 741 at 12.61
6.5%
Not planned
20 Mar 2023
Trevejo Jose M. CHIEF MEDICAL OFFICER
Sold at will
$6.68K 530 at 12.61
6.5%
Not planned
20 Mar 2023
Neervannan Seshadri Chief Operating Officer
Sold at will
$4.79K 380 at 12.61
0.7%
Not planned
20 Mar 2023
Mottiwala Aziz Chief Commercial Officer
Sold at will
$4.51K 358 at 12.61
0.7%
Not planned
20 Mar 2023
Wahl Bryan General Counsel
Sold at will
$4.50K 357 at 12.61
2.0%
Not planned
20 Mar 2023
Whitfield Dianne C. Chief Human Resources Officer
Sold at will
$4.20K 333 at 12.61
2.7%
Not planned
20 Mar 2023
Greenstein Leonard M. Chief Financial Officer
Sold at will
$4.20K 333 at 12.61
1.0%
Not planned
20 Mar 2023
Holdbrook Mark J. V.P., Clinical Affairs
Sold at will
$2.50K 198 at 12.61
5.8%
Not planned
17 Mar 2023
Azamian Bobak R. President/CEO and Board Chair
Sold at will
$10.56K 795 at 13.28
6.5%
Not planned
17 Mar 2023
Trevejo Jose M. CHIEF MEDICAL OFFICER
Sold at will
$6.69K 504 at 13.28
5.8%
Not planned
17 Mar 2023
Neervannan Seshadri Chief Operating Officer
Sold at will
$4.78K 360 at 13.28
0.6%
Not planned
17 Mar 2023
Wahl Bryan General Counsel
Sold at will
$4.50K 339 at 13.28
1.9%
Not planned
17 Mar 2023
Mottiwala Aziz Chief Commercial Officer
Sold at will
$4.50K 339 at 13.28
0.6%
Not planned
17 Mar 2023
Whitfield Dianne C. Chief Human Resources Officer
Sold at will
$4.20K 316 at 13.28
2.5%
Not planned
17 Mar 2023
Greenstein Leonard M. Chief Financial Officer
Sold at will
$4.20K 316 at 13.28
0.9%
Not planned
17 Mar 2023
Holdbrook Mark J. V.P., Clinical Affairs
Sold at will
$2.50K 188 at 13.28
5.3%
Not planned
16 Mar 2023
Greenstein Leonard M. Chief Financial Officer
Sold, plan not stated 2×
$71.40K 5,313 at 13.44
13.7%
16 Mar 2023
Azamian Bobak R. President/CEO and Board Chair
Sold, plan not stated
$10.62K 791 at 13.43
6.1%
16 Mar 2023
Trevejo Jose M. Chief Medical Officer
Sold, plan not stated
$6.70K 499 at 13.43
5.5%
16 Mar 2023
Neervannan Seshadri Chief Operating Officer
Sold, plan not stated
$4.79K 357 at 13.43
0.6%
16 Mar 2023
Wahl Bryan General Counsel
Sold, plan not stated
$4.53K 337 at 13.43
1.8%
16 Mar 2023
Mottiwala Aziz Chief Commercial Officer
Sold, plan not stated
$4.51K 336 at 13.43
0.6%
16 Mar 2023
Whitfield Dianne C. Chief Human Resources Officer
Sold, plan not stated
$4.20K 313 at 13.43
2.4%
16 Mar 2023
Holdbrook Mark J. V.P., Clinical Affairs
Sold, plan not stated
$2.51K 187 at 13.43
5.0%
15 Mar 2023
Azamian Bobak R. President/CEO and Board Chair · indirect
Sold, plan not stated
$110.32K 8,000 at 13.79
0.7%
9 Mar 2023
Azamian Bobak R. President/CEO and Board Chair · indirect
Sold, plan not stated
$10.76K 717 at 15.01
0.1%
Showing 101–150 of 227. ← Newer Page 3 of 5 Older →